Invernadero, Inc. — Patented Biotech Delivery Platforms
Public Benefit Corporation — Tacoma, WA

Patented delivery.
Purposeful science.

Where human potential grows.

An independent biotech building proprietary penetration enhancement and nutrient delivery platforms for populations the industry has left behind. Patents filed. Federal grant in progress.

Filed PatentsSBIR Phase IPublic Benefit CorpTopical DeliveryNutrient BioavailabilityIndependent R&D
01

Development Pipeline

✓
Provisional Filed
✓
In Silico Studies
→
Non-Provisional Filing
→
SBIR Phase I Submission
02

Platform Portfolio

Platform 01 — Topical
AdaptaFusion
PCA-Based Penetration Enhancement
Topical delivery platform targeting burn wound management across four severity classifications. In silico ADMET and PK modeling complete. Co-PI with 17 issued patents.
Non-Provisional Pending · SBIR Phase I Target
Platform 02 — Ingestible
Multi-Modal Nutrient Delivery
Tri-Layer Tablet System
Ingestible platform delivering immediate, delayed, and extended release in a single dosage unit. Clinical nutrition and consumer wellness applications.
Non-Provisional Pending · Stealth Until Filing
03

Credibility Markers

4
Provisional Patents Filed
2
Non-Provisionals In Prosecution
PBC
Public Benefit Corp Status
NIH
SBIR Phase I Target Funder
04

Leadership

Founder, CEO & Principal Investigator
Tamra Bunn
Self-funded independent researcher and formulator. Built four provisional patents and a live supplement brand. PI on NIH SBIR Phase I.
Co-Founder & Co-PI
Patent Agent & Scientist
Registered USPTO patent agent. Doctoral credentials. Multi-patent portfolio. Co-PI on SBIR Phase I.
Patent Counsel
Registered Patent Attorney
Registered USPTO patent attorney. Portfolio strategy and prosecution. Credentials verified.

Forward-looking statements: Research pipeline and grant applications subject to change. Patents pending, not issued. Nothing herein is an offer to sell securities.